MiNK Therapeutics Inc. (NASDAQ: INKT) Stock Information | RedChip

MiNK Therapeutics Inc. (NASDAQ: INKT) Listen to this Section


$0.81
-0.0160 ( -1.95% ) 40.8K

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Market Data


Open


$0.81

Previous close


$0.82

Volume


40.8K

Market cap


$31.88M

Day range


$0.81 - $0.84

52 week range


$0.75 - $1.90

Insider Ownership Transactions

Total Amount Purchased: -650,815.00 | $ -523,906.08

Date Type Amount Purchased Purchaser
2024-06-05 Sale -15077.00 WIINBERG ULF
2024-06-05 Sale -17967.00 Corvese Brian
2024-06-05 Sale -15454.00 Behner Peter
2024-06-05 Sale -17841.00 Ryan Barbara
2024-03-05 Sale -18816.00 Corvese Brian
2024-03-05 Sale -18685.00 Ryan Barbara
2024-03-05 Sale -16185.00 Behner Peter
2024-03-05 Sale -15790.00 WIINBERG ULF
2024-01-18 Sale -15000.00 van Dijk Marcus Antonius
2024-01-18 Sale -500000.00 Buell Jennifer

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 52 Aug 13, 2024
8-k 8K-related 15 Aug 13, 2024
8-k 8K-related 11 Jun 17, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
8-k 8K-related 11 May 16, 2024
10-q Quarterly Reports 51 May 14, 2024
8-k 8K-related 15 May 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.